
Finerenone + SGLT2i Combo Shows Promise in CKD with Type 2 Diabetes
Simultaneous Use of Finerenone and SGLT-2 Inhibitor Demonstrates Significant Clinical Benefit in CKD Patients with Type 2 Diabetes, Bayer Reports Finerenone + SGLT2i In a breakthrough for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes (T2D),…